Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial
Vall d'Hebron Hospital Universitari · Auckland Institute of Studies · +16 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
542
total citations
- FWCI
- 36.25
- Percentile
- 100%
- References
- 52
Citations per year
Authors
22Topics & keywords
Topics
Keywords
- Tenofovir alafenamide
- Tenofovir
- Medicine
- Double blind
- Virology
- Chronic hepatitis
- Internal medicine
- Virus
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.